Biocept, Inc. (BIOCQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 26, 2024, 4:00 PM EST
Biocept Revenue
Biocept had revenue of $589.00K in the quarter ending June 30, 2023, a decrease of -89.88%. This brings the company's revenue in the last twelve months to $1.36M, down -97.63% year-over-year. In the year 2022, Biocept had annual revenue of $25.86M, down -57.78%.
Revenue (ttm)
1.36M
Revenue Growth
-97.63%
P/S Ratio
n/a
Revenue / Employee
27.14K
Employees
50
Market Cap
3.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 25.86M | -35.39M | -57.78% |
| Dec 31, 2021 | 61.25M | 33.79M | 123.04% |
| Dec 31, 2020 | 27.46M | 21.93M | 396.71% |
| Dec 31, 2019 | 5.53M | 2.28M | 70.09% |
| Dec 31, 2018 | 3.25M | -1.82M | -35.87% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |